Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2007-08-21

Clinical Trial Update: The Effects of ProAlgaZyme on HDL Cholesterol in Individuals With Metabolic Syndrome [NA]

View source ↗

Summary

A clinical trial update examining the effect of ProAlgaZyme on HDL cholesterol in people with metabolic syndrome and hyperlipidemia; the trial status is current…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ProAlgaZyme

Snippet

Sponsor: Health Enhancement Products, Inc. | Conditions: Metabolic Syndrome, Hyperlipidemia | NA | Status: UNKNOWN